Viewing Study NCT00436605


Ignite Creation Date: 2025-12-25 @ 3:24 AM
Ignite Modification Date: 2026-06-04 @ 3:38 AM
Study NCT ID: NCT00436605
Status: COMPLETED
Last Update Posted: 2014-05-15
First Post: 2007-02-15
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: Dasatinib in Treating Patients With Stage III Melanoma That Cannot Be Removed By Surgery or Stage IV Melanoma
Sponsor: National Cancer Institute (NCI)
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Recurrent Melanoma View
None Stage IIIA Melanoma View
None Stage IIIB Melanoma View
None Stage IIIC Melanoma View
None Stage IV Melanoma View
Keywords: